Species-Specific Bacteria Identification Using Differential Mobility Spectrometry and Bioinformatics Pattern Recognition

Marianna Shnayderman(Massachusetts General Hospital), Cristina E. Davis(Massachusetts General Hospital), Melissa D. Krebs(Massachusetts General Hospital), Sarah J. Cohen(Massachusetts General Hospital), Brian C. Mansfield(Massachusetts General Hospital), Henry L. Dorkin(Boston Children's Hospital), Edward T. Ryan(Harvard University), Christopher Gill(Gates Foundation), Heather A. Clark(Arizona State University), Jeffrey A. Gelfand(Harvard University), Ben A. Hitt(Massachusetts General Hospital), Thomas O. Stair(Massachusetts General Hospital), Michael V. Callahan(Massachusetts General Hospital), Ping Yip(Massachusetts General Hospital), Julie E. Zeskind(Massachusetts General Hospital)
Analytical Chemistry
August 12, 2005
10.1021/ac050348i
Cited by 87

Related Papers

SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
|PLoS Medicine|2006|823
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis
|New England Journal of Medicine|1993|458
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
|Immunity|2020|420